CODX

Co-Diagnostics Inc.

Price

$0.95

return (12m)

-92.80%

p/e

-0.09

p/bv

0.33

DIVIDEND YIELD

0.00%

CODX price

Co-Diagnostics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CODX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-24.34%

3 months

-69.69%

1 year

-92.80%

2 years

-97.56%

5 years

-99.68%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CODX

Valuation

P/E

-0.09

Sector 1.09

Industry -1.78

P/BV

0.33

Sector 1.86

Industry 1.35

P/Revenue (PSR)

5.86

Sector 1.55

Industry 2.25

EV/EBITDA

-0.10

Sector -47.62

Industry -42.38

EV/EBIT

-0.09

Sector -27.52

Industry -45.58

P/EBITDA

-0.15

Sector -32.64

Industry -23.10

P/EBIT

-0.14

Sector -43.02

Industry -27.18

P/Total Assets

0.25

Sector 0.87

Industry 0.82

P/Net Current Assets

3.21

Sector -27.09

Industry -72.46

P/Working Capital

1.81

Sector -4.05

Industry -2.10

EPS

-10.92

Sector -0.70

Industry -1.11

BVPS

2.95

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

43.55%

Sector 49.36%

Industry 50.48%

EBITDA Margin

-3,613.86%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

-3,735.54%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

-100.00%

Sector -19.73%

Industry -25.75%

Net Profit Margins

-100.00%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.01

Sector 0.13

Industry 0.06

Profitability

ROE

-370.18%

Sector -24.32%

Industry -33.33%

ROA

-283.63%

Sector -24.41%

Industry -45.72%

ROIC

-199.20%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.81

Sector 1.90

Industry 2.51

Net Debt / EBITDA

0.61

Sector -4.96

Industry -8.98

Net Debt / EBIT

0.59

Sector -3.08

Industry -37.38

Net Debt / Equity

-0.29

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.00

Sector -0.74

Industry -0.56

Equity/Assets

0.77

Sector 0.46

Industry 0.52

Liabilities/Assets

0.23

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

-62.55%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals CODX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CODX Co-Diagnostics Inc.	$0.95	-92.80%	0.00%	-0.09	0.33	-370.18%	-100.00%
ISRG Intuitive Surgical Inc.	$393.33	-10.35%	0.00%	44.01	7.60	17.26%	28.62%
ABT Abbott Laboratories	$102.61	-22.85%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.13	0.84%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.34	-55.70%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$86.42	-29.33%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$224.99	-16.77%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$511.65	-22.02%	0.00%	35.48	25.07	70.67%	25.03%
COHR Coherent Inc.	$317.36	190.86%	0.00%	75.62	5.36	7.09%	11.19%
SYK Stryker Corp.	$275.12	-26.01%	1.26%	28.38	4.41	15.55%	14.43%
PHG Koninklijke Philips NV	$24.69	-8.66%	4.11%	18.19	1.78	9.80%	6.30%
INMD InMode Ltd.	$14.35	-2.38%	0.00%	10.90	1.34	12.32%	20.69%
DXCM DexCom Inc.	$89.35	32.47%	0.00%	33.89	12.92	38.14%	20.12%
BDX Becton Dickinson and Company	$180.94	-0.31%	2.34%	52.21	2.01	3.86%	6.30%
EW Edwards Lifesciences Corp.	$88.26	18.61%	0.00%	50.69	4.74	9.36%	15.41%
ALGN Align Technology Inc.	$147.61	12.34%	0.00%	27.43	2.68	9.77%	9.99%
SNN Smith & Nephew PLC	$27.58	-22.60%	2.80%	19.48	4.52	23.22%	9.83%
IRMD iRadimed Corporation	$82.12	17.79%	1.54%	45.76	10.37	22.66%	26.70%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CODX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Co-Diagnostics

Co-Diagnostics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

13 years

Founded: 2013

2017

Time since IPO - 9 years

37

Employees

Co-Diagnostics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $4.22 million, with shareholders equity totaling $12.71 million.

The company employs approximately 37 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Co-Diagnostics Inc. reported $721.00 Thousand in revenue, generating net income of $-47.06 million.

Key financial metrics include a P/E ratio of -0.09, a price-to-book (P/B) ratio of 0.33, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CODX.

Market cap

$4.22 million

Net worth

$12.71 million

$12,712,000.00

Assets

$16.59 million

$16,591,000.00

Total Shares Outstanding

4.31 million

4,309,000

Average Daily Trading Volume

$332.85 Thousand

$332,854.56

Sector

Health

Industry

Medical Supplies and Equipment

CODX

CODX revenue and profits

Financial Results CODX

DRAG THE FRAME TO SEE MORE DATA

CODX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.84 22,33% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.28 --3,05% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.11 104,94% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$386.22 55,41% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.48 --7,32% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,152.93 54,29% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$427.71 7,02% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$140.37 16,41% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35